The infection of a novel coronavirus found in Wuhan of China (SARS-CoV-2) is rapidly spreading, and the incidence rate is increasing worldwide. Due to the lack of effective …
Previously, our group predicted commercially available Food and Drug Administration (FDA) approved drugs that can inhibit each step of the replication of severe acute respiratory …
The coronavirus disease 2019 (COVID-19) pandemic has claimed many lives since it was first reported in late December 2019. However, there is still no drug proven to be effective …
CT Ting, BS Chen - International Journal of Molecular Sciences, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) epidemic is currently raging around the world at a rapid speed. Among COVID-19 patients, SARS-CoV-2-associated acute respiratory …
M Abdel-Basset, H Hawash, M Elhoseny… - Ieee …, 2020 - ieeexplore.ieee.org
The rapid spread of novel coronavirus pneumonia (COVID-19) has led to a dramatically increased mortality rate worldwide. Despite many efforts, the rapid development of an …
The pandemic threat of COVID-19 has severely destroyed human life as well as the economy around the world. Although, the vaccination has reduced the outspread, but …
Background The recent global pandemic has placed a high priority on identifying drugs to prevent or lessen clinical infection of severe acute respiratory syndrome coronavirus 2 …
Q Yin, R Fan, X Cao, Q Liu, R Jiang… - Quantitative …, 2023 - Wiley Online Library
Computational methods for DDIs and DTIs prediction are essential for accelerating the drug discovery process. We proposed a novel deep learning method DeepDrug, to tackle these …
Z Huang, P Zhang, L Deng - Bioinformatics, 2023 - academic.oup.com
Motivation The coronavirus disease 2019 (COVID-19) remains a global public health emergency. Although people, especially those with underlying health conditions, could …